• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核糖体生物发生与癌症的关联。

The Ribosome Biogenesis-Cancer Connection.

机构信息

Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, 40138 Bologna, Italy.

Center for Applied Biomedical Research (CRBA), Alma Mater Studiorum-University of Bologna, 40138 Bologna, Italy.

出版信息

Cells. 2019 Jan 15;8(1):55. doi: 10.3390/cells8010055.

DOI:10.3390/cells8010055
PMID:30650663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6356843/
Abstract

Multifaceted relations link ribosome biogenesis to cancer. Ribosome biogenesis takes place in the nucleolus. Clarifying the mechanisms involved in this nucleolar function and its relationship with cell proliferation: 1) allowed the understanding of the reasons for the nucleolar changes in cancer cells and their exploitation in tumor pathology, 2) defined the importance of the inhibition of ribosome biogenesis in cancer chemotherapy and 3) focused the attention on alterations of ribosome biogenesis in the pathogenesis of cancer. This review summarizes the research milestones regarding these relevant relationships between ribosome biogenesis and cancer. The structure and function of the nucleolus will also be briefly described.

摘要

核糖体生物发生与癌症之间存在多方面的关系。核糖体生物发生发生在核仁中。阐明涉及核仁功能及其与细胞增殖的关系的机制:1)使人们了解癌细胞中核仁变化的原因及其在肿瘤病理学中的应用,2)确定抑制核糖体生物发生在癌症化疗中的重要性,3)关注核糖体生物发生在癌症发病机制中的改变。这篇综述总结了关于核糖体生物发生与癌症之间这些相关关系的研究里程碑。核仁的结构和功能也将简要描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/e7c31b9bc632/cells-08-00055-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/05cc6ef19aff/cells-08-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/3d30186a13c1/cells-08-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/1db91cfbd282/cells-08-00055-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/0a81ee982fc9/cells-08-00055-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/e7c31b9bc632/cells-08-00055-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/05cc6ef19aff/cells-08-00055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/3d30186a13c1/cells-08-00055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/1db91cfbd282/cells-08-00055-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/0a81ee982fc9/cells-08-00055-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb7/6356843/e7c31b9bc632/cells-08-00055-g005.jpg

相似文献

1
The Ribosome Biogenesis-Cancer Connection.核糖体生物发生与癌症的关联。
Cells. 2019 Jan 15;8(1):55. doi: 10.3390/cells8010055.
2
Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism.功能性核糖体生物发生是 p53 不稳定的前提条件:化疗对核仁功能和 RNA 代谢的影响。
Biol Chem. 2013 Sep;394(9):1133-43. doi: 10.1515/hsz-2013-0153.
3
The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.RRP15在人类细胞的核仁形成、核糖体生物合成及检查点控制中的作用。
Oncotarget. 2017 Feb 21;8(8):13240-13252. doi: 10.18632/oncotarget.14658.
4
Nucleolar stress: From development to cancer.核仁应激:从发育到癌症。
Semin Cell Dev Biol. 2023 Feb 28;136:64-74. doi: 10.1016/j.semcdb.2022.04.001. Epub 2022 Apr 8.
5
Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.HEATR1 缺失导致 RNA 聚合酶 I 转录机制受到干扰,从而在人细胞中引发 RPL5/RPL11-MDM2-p53 核糖体生物发生应激检查点途径。
Cell Cycle. 2018;17(1):92-101. doi: 10.1080/15384101.2017.1403685. Epub 2017 Dec 10.
6
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.核糖体生物合成受损时肿瘤抑制因子p53的激活。
Biochim Biophys Acta. 2014 Jun;1842(6):817-30. doi: 10.1016/j.bbadis.2013.08.014. Epub 2013 Oct 26.
7
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis.核仁 SUMO 异肽酶的特性揭示了核糖体生物发生受损的普遍的 p53 非依赖性检查点。
Nat Commun. 2023 Dec 8;14(1):8121. doi: 10.1038/s41467-023-43751-9.
8
Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress.核糖体蛋白在核仁应激期间控制或绕过p53。
Int J Mol Sci. 2017 Jan 12;18(1):140. doi: 10.3390/ijms18010140.
9
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction.40S核糖体生物合成受损后核仁未发生破坏,揭示了一种p53诱导的rpL11翻译依赖性机制。
Nat Cell Biol. 2009 Apr;11(4):501-8. doi: 10.1038/ncb1858. Epub 2009 Mar 15.
10
p53 and ribosome biogenesis stress: the essentials.p53 与核糖体生物发生应激:要点。
FEBS Lett. 2014 Aug 19;588(16):2571-9. doi: 10.1016/j.febslet.2014.04.014. Epub 2014 Apr 18.

引用本文的文献

1
Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior.RPL15过表达在肝内胆管癌中的预后影响:侵袭性肿瘤行为的一个标志物
Diagn Pathol. 2025 Sep 1;20(1):101. doi: 10.1186/s13000-025-01699-y.
2
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
3
Blood-based transcriptomic biomarkers for response to [Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors.

本文引用的文献

1
40 Years of Research Put p53 in Translation.40年的研究成果将p53转化为实际应用。
Cancers (Basel). 2018 May 21;10(5):152. doi: 10.3390/cancers10050152.
2
Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis.核仁作为维持基因组稳定性和癌症发病机制的新兴枢纽。
Oncogene. 2018 May;37(18):2351-2366. doi: 10.1038/s41388-017-0121-z. Epub 2018 Feb 12.
3
Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.癌症突变的核糖体蛋白L22(RPL22/eL22)通过阻断p53-MDM2回路来抑制癌细胞存活。
用于神经内分泌肿瘤中[镥]镥-多胺酸-奥曲肽治疗反应的血液转录组学生物标志物。
EJNMMI Res. 2025 Aug 2;15(1):100. doi: 10.1186/s13550-025-01284-w.
4
Identification and Characterization of the RNA Modifying Factors PUS7 and WTAP as Key Components for the Control of Tumor Biological Processes in Renal Cell Carcinomas.RNA修饰因子PUS7和WTAP作为肾细胞癌肿瘤生物学过程控制关键成分的鉴定与表征
Curr Issues Mol Biol. 2025 Apr 9;47(4):266. doi: 10.3390/cimb47040266.
5
miR-7-5p and Importin-7 Regulate the p53 Dynamics and Stability in Malignant and Benign Thyroid Cells.miR-7-5p与输入蛋白7调节恶性和良性甲状腺细胞中p53的动力学及稳定性
Int J Mol Sci. 2025 Jun 17;26(12):5813. doi: 10.3390/ijms26125813.
6
Ribosome biogenesis: A central player in liver diseases.核糖体生物发生:肝脏疾病中的核心因素。
Genes Dis. 2025 Jan 4;12(5):101512. doi: 10.1016/j.gendis.2025.101512. eCollection 2025 Sep.
7
Emerging roles for the nucleolus in development and stem cells.核仁在发育和干细胞中的新作用。
Development. 2025 May 1;152(9). doi: 10.1242/dev.204696. Epub 2025 May 14.
8
Highly conserved ribosome biogenesis pathways between human and yeast revealed by the MDN1-NLE1 interaction and NLE1 containing pre-60S subunits.MDN1与NLE1的相互作用以及含NLE1的前60S亚基揭示了人类和酵母之间高度保守的核糖体生物发生途径。
Nucleic Acids Res. 2025 Apr 10;53(7). doi: 10.1093/nar/gkaf255.
9
RBIS as a prognostic biomarker for progression-free survival in prostate cancer: insights from bioinformatics and immune infiltration analysis.RBIS作为前列腺癌无进展生存期的预后生物标志物:来自生物信息学和免疫浸润分析的见解
Discov Oncol. 2025 Mar 11;16(1):297. doi: 10.1007/s12672-025-02083-4.
10
Periodic tryptophan protein 1 promotes colorectal cancer growth via ribosome biogenesis.周期性色氨酸蛋白1通过核糖体生物合成促进结直肠癌生长。
Int J Clin Oncol. 2025 May;30(5):944-955. doi: 10.1007/s10147-025-02733-1. Epub 2025 Mar 9.
Oncotarget. 2017 Oct 6;8(53):90651-90661. doi: 10.18632/oncotarget.21544. eCollection 2017 Oct 31.
4
Ribosomopathies: There's strength in numbers.核糖体病:众志成城。
Science. 2017 Nov 3;358(6363). doi: 10.1126/science.aan2755.
5
Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.十五年随访后国立癌症研究所遗传性骨髓衰竭综合征队列中的癌症。
Haematologica. 2018 Jan;103(1):30-39. doi: 10.3324/haematol.2017.178111. Epub 2017 Oct 19.
6
p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.p53 介导先天性角化不良症中人类确定性造血失败。
Stem Cell Reports. 2017 Aug 8;9(2):409-418. doi: 10.1016/j.stemcr.2017.06.015. Epub 2017 Jul 27.
7
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.核糖体蛋白-MDM2-p53信号通路:连接核糖体生物合成与肿瘤监测
Trends Cancer. 2016 Apr;2(4):191-204. doi: 10.1016/j.trecan.2016.03.002. Epub 2016 Apr 4.
8
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with mutations.核糖体蛋白基因的缺失是人类癌症中的一种常见脆弱性,尤其是与突变共同作用时。
EMBO Mol Med. 2017 Apr;9(4):498-507. doi: 10.15252/emmm.201606660.
9
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.一部分含铂化疗药物通过诱导核糖体生物合成应激来杀死细胞。
Nat Med. 2017 Apr;23(4):461-471. doi: 10.1038/nm.4291. Epub 2017 Feb 27.
10
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.CX-5461 是一种 DNA G-四链体稳定剂,对 BRCA1/2 缺陷型肿瘤具有选择性致死作用。
Nat Commun. 2017 Feb 17;8:14432. doi: 10.1038/ncomms14432.